KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of GoodwillCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edgewell Personal Care (EPC) Other financing activities (2016 - 2025)

Edgewell Personal Care (EPC) has disclosed Other financing activities for 16 consecutive years, with -$100000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Other financing activities rose 92.86% to -$100000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$400000.0, a 90.7% increase, with the full-year FY2025 number at -$400000.0, up 90.7% from a year prior.
  • Other financing activities was -$100000.0 for Q3 2025 at Edgewell Personal Care, up from -$300000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $5.9 million in Q1 2021 to a low of -$6.9 million in Q3 2021.
  • A 5-year average of -$300000.0 and a median of -$100000.0 in 2024 define the central range for Other financing activities.
  • Peak YoY movement for Other financing activities: soared 300.0% in 2023, then plummeted 1250.0% in 2024.
  • Edgewell Personal Care's Other financing activities stood at $400000.0 in 2021, then plummeted by 75.0% to $100000.0 in 2022, then tumbled by 600.0% to -$500000.0 in 2023, then crashed by 180.0% to -$1.4 million in 2024, then surged by 92.86% to -$100000.0 in 2025.
  • Per Business Quant, the three most recent readings for EPC's Other financing activities are -$100000.0 (Q3 2025), -$300000.0 (Q2 2025), and -$1.4 million (Q3 2024).